Skip to main content
250-Declan-Murphy

Professor Declan Murphy

Professor

Biography

Professor Murphy is Professor of Translational Neurodevelopment, and Director of the Institute of Translational Neurodevelopment, Institute of Psychiatry, Psychology & Neuroscience (IoPPN).

He is also the Head of Department, Forensic and Neurodevelopmental Sciences, IoPPN.  Clinically he is Director of the Behavioural and Developmental Psychiatry Clinical Academic Group, King’s Health Partners, King’s College London. His overarching mission is to translate research from ‘bench to bedside’; to improve  understanding of mechanisms that modulate risk vs resilience, and so develop new diagnostic approaches, treatments, and services. 

Professor Murphy trained in medicine at University College London, and Westminster Medical school.  He subsequently trained in psychiatry at the Maudsley Hospital; and his research training was at the Institute of Psychiatry (London) and the Laboratory of Neurosciences at the National Institutes of Health (USA). 

In autism Professor Murphy established the MRC UK AIMS multi centre imaging network – the first in Europe.  From this he developed two European Union funded Innovative Medicines Initiatives in autism.  The first was called EU-AIMS (http://www.eu-aims.eu/). The successor to this (EU AIMS-2-TRIALS) (https://www.aims-2-trials.eu/) brings together 48 partners (including academics, charities, autistic individuals and families, regulators and industry) across 14 European countries. The research programme includes a range of studies. These will explore how autism develops, from before birth to adulthood, and how this varies in different people. We will look for biological markers which indicate whether a person has, or may develop, particular characteristics. These markers may help to identify who could ultimately benefit from particular treatments. We will also test treatments.   EU AIMS-2-TRIALS  links to other groups in North America, South Africa, China, Australia, and Pakistan 

Research Interests

His main interest is in normal brain development, and how abnormalities in this process lead to neurodevelopmental/neuropsychiatric disorders.  He supervises PhD Students in 

  • Fetal/neonatal/infant brain development 
  • Brain changes across the lifespan 
  • Risk vs protective mechanisms underpinning the emergence of a variety of neurodevelopmental disorders including  autism, ADHD, epilepsy and psychosis.  And factors modulating outcome and response to treatment  
  • Disorders of social behaviour in children and adults – e.g. conduct disorder, callous unemotional behaviour, and psychopathy 
  • The impact of specific genetic abnormalities on brain and behaviour 
  • Biomarker discovery and validation. 
  • Treatment trials (including non pharmacological approaches). 
  • Pharmacochallenge studies using brain imaging 

Expertise and Public Engagement 

Professor Murphy has frequently appeared in National and International Media – including TV, radio, and print. 

Research

EU-AIMS (European Autism Interventions)

One of the largest ever research projects finding new ways to develop drugs for autism spectrum disorder (ASD).

header abstract 1
Institute for Translational Neurodevelopment

The Institute for Translational Neurodevelopment was launched in 2013 and carries out multidisciplinary ‘translational’ studies of normal development, and how abnormalities in that process lead to high cost neurodevelopmental disorders.

News

New study uses psilocybin to examine the serotonin system in autism

A new study, led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London will explore the potential...

drugs-penci

Events

16JunEva Loth inaugural lecture

Professor Eva Loth - Inaugural Lecture

Join us in celebrating Professor Eva Loth's inaugural lecture on 'The role of concepts, trends and lived experience in autism research'

Please note: this event has passed.

12JanTranslating Neuroscience – across species, across development and into clinic

Professor Gráinne McAlonan - Inaugural Lecture

Join us in celebrating Professor Gráinne McAlonan's inaugural lecture on 'Translating Neuroscience – across species, across development and into clinic''

Please note: this event has passed.

MSc in Clinical Developmental Neurosciences 

Research

EU-AIMS (European Autism Interventions)

One of the largest ever research projects finding new ways to develop drugs for autism spectrum disorder (ASD).

header abstract 1
Institute for Translational Neurodevelopment

The Institute for Translational Neurodevelopment was launched in 2013 and carries out multidisciplinary ‘translational’ studies of normal development, and how abnormalities in that process lead to high cost neurodevelopmental disorders.

News

New study uses psilocybin to examine the serotonin system in autism

A new study, led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London will explore the potential...

drugs-penci

Events

16JunEva Loth inaugural lecture

Professor Eva Loth - Inaugural Lecture

Join us in celebrating Professor Eva Loth's inaugural lecture on 'The role of concepts, trends and lived experience in autism research'

Please note: this event has passed.

12JanTranslating Neuroscience – across species, across development and into clinic

Professor Gráinne McAlonan - Inaugural Lecture

Join us in celebrating Professor Gráinne McAlonan's inaugural lecture on 'Translating Neuroscience – across species, across development and into clinic''

Please note: this event has passed.

MSc in Clinical Developmental Neurosciences